Aprotinin in Neonates Undergoing Cardiopulmonary Bypass

Completed

Conditions studied: Cardiopulmonary Bypass, Congenital Defects, Hemostasis

In brief

This is a retrospective chart review study. The purpose of this study is to review our experience at Children's Healthcare of Atlanta in neonates receiving aprotinin. We will examine the specific outcomes of renal dysfunction, thrombosis and mortality.

Key facts

Study ID

NCT00469742

Run by

Children's Healthcare of Atlanta

People needed

290

Starts

2007-04-01

Expected to finish

2008-12-01

Last updated by the study team

2012-03-16

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Neonates who underwent Cardiopulmonary Bypass (CPB) at Children's Healthcare of Atlanta between March 2004 and March 2007.

You may not qualify if…

• All candidates who do not meet inclusion criteria.

Where it is running

• Children's Healthcare of Atlanta — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.